Results
265
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
265 companies
HLB Pep
Market Cap: ₩64.5b
A bio-venture company, engages in the manufacture and sale of peptide biomaterials and drug raw materials in South Korea and internationally.
A196300
₩6,940.00
7D
-4.7%
1Y
-41.8%
SCM Lifescience
Market Cap: ₩44.6b
Operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses.
A298060
₩1,130.00
7D
-8.4%
1Y
-46.3%
MedPacto
Market Cap: ₩147.4b
A drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea.
A235980
₩4,300.00
7D
-6.3%
1Y
-31.0%
Kangstem Biotech
Market Cap: ₩140.1b
A biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases.
A217730
₩1,490.00
7D
-6.9%
1Y
-14.4%
Daesung Microbiological Labs
Market Cap: ₩29.0b
Manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea.
A036480
₩7,640.00
7D
-4.1%
1Y
-24.1%
Dongwha Pharm.Co.Ltd
Market Cap: ₩176.0b
Manufactures and sells pharmaceutical products in South Korea.
A000020
₩6,350.00
7D
-0.3%
1Y
-18.7%
APTOCROM
Market Cap: ₩72.2b
Distributes pharmaceutical products in South Korea.
A109960
₩327.00
7D
-9.4%
1Y
-38.9%
Xcell Therapeutics
Market Cap: ₩32.9b
Engages in the development and production of drugs for cell therapy.
A373110
₩3,005.00
7D
-8.2%
1Y
-63.1%
ViGenCell
Market Cap: ₩80.0b
Specializes in immune cell therapy.
A308080
₩3,910.00
7D
0%
1Y
4.4%
Ark Solutions
Market Cap: ₩68.9b
Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.
A203690
₩4,425.00
7D
0%
1Y
-63.6%
BNC Korea
Market Cap: ₩342.0b
Engages in the research and development, production, and sale of biomaterials for medicines in South Korea.
A256840
₩5,000.00
7D
-3.5%
1Y
-13.0%
Kyung Nam PharmLtd
Market Cap: ₩46.4b
Engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia.
A053950
₩594.00
7D
-3.6%
1Y
-24.6%
PharmGen Science
Market Cap: ₩82.3b
Engages in the research and development, production, and sale of pharmaceutical products in South Korea.
A004720
₩4,390.00
7D
-4.4%
1Y
-12.4%
Onconic Therapeutics
Market Cap: ₩584.2b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩52,800.00
7D
17.1%
1Y
n/a
Kwang Dong Pharmaceutical
Market Cap: ₩231.0b
Operates as a human healthcare provider in South Korea.
A009290
₩5,880.00
7D
-0.5%
1Y
-0.5%
GI Innovation
Market Cap: ₩1.1t
A bio-venture company, engages in the research and development of protein new drugs.
A358570
₩17,780.00
7D
-7.1%
1Y
60.0%
Shaperon
Market Cap: ₩80.6b
A clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics.
A378800
₩2,675.00
7D
24.7%
1Y
-34.2%
Helixmith
Market Cap: ₩286.0b
Develops biologic and natural nutraceutical products.
A084990
₩6,210.00
7D
0.6%
1Y
78.7%
Quratis
Market Cap: ₩69.9b
Engages in developing vaccines in South Korea.
A348080
₩946.00
7D
-8.2%
1Y
2.4%
NeoImmuneTech
Market Cap: ₩74.4b
A clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.
A950220
₩753.00
7D
-12.8%
1Y
-46.2%
Seoulin BioscienceLtd
Market Cap: ₩56.2b
A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.
A038070
₩6,520.00
7D
-3.4%
1Y
-13.2%
Korea Arlico PharmLtd
Market Cap: ₩62.8b
Engages in the researches and develops, produces, and sells medicines in South Korea.
A260660
₩4,100.00
7D
-7.2%
1Y
-1.2%
TechnologyLtd
Market Cap: ₩4.7b
Manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea.
A043090
₩380.00
7D
0%
1Y
-84.2%
Green Cross Holdings
Market Cap: ₩713.3b
Operates as a biotechnology company.
A005250
₩15,650.00
7D
-6.6%
1Y
0.4%
BCWORLD PHARM
Market Cap: ₩38.1b
Operates as a pharmaceutical company in South Korea.
A200780
₩4,510.00
7D
3.2%
1Y
-1.4%
GW VitekLTD
Market Cap: ₩53.9b
Engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally.
A036180
₩577.00
7D
0%
1Y
-20.3%
NanoEntek
Market Cap: ₩111.7b
Engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally.
A039860
₩3,480.00
7D
-1.7%
1Y
7.4%
Tdspharm
Market Cap: ₩54.8b
Researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally.
A464280
₩9,910.00
7D
-2.9%
1Y
-52.1%
Kainos Medicine
Market Cap: ₩35.6b
Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.
A284620
₩1,087.00
7D
0%
1Y
-76.5%
ToolGen
Market Cap: ₩320.5b
A biotechnology company, focuses on the development of genome editing technology in South Korea.
A199800
₩37,350.00
7D
-0.1%
1Y
-33.1%
Peptron
Market Cap: ₩6.5t
Engages in the development of peptide-based medicines.
A087010
₩277,500.00
7D
-4.1%
1Y
418.7%
HLB PANAGENE
Market Cap: ₩76.4b
Develops products in the field of molecular diagnostics in South Korea.
A046210
₩1,694.00
7D
-0.3%
1Y
-46.7%
Jeil Pharma Holdings
Market Cap: ₩133.4b
Manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea.
A002620
₩8,690.00
7D
0.2%
1Y
-2.7%
GENINUS
Market Cap: ₩67.9b
A bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea.
A389030
₩2,035.00
7D
-1.2%
1Y
29.3%
Prestige BioPharma
Market Cap: ₩161.2b
A biopharmaceutical company, engages in the research and development and marketing of biosimilars, first-in-class antibody drugs, and vaccines.
A950210
₩13,410.00
7D
-8.7%
1Y
-4.1%
Kolon TissueGene
Market Cap: ₩3.9t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩47,300.00
7D
4.9%
1Y
243.3%